An enzyme from the bacterium Escherichia coli is the 'special observed' in colon cancer

Tuesday 19 December 2023
This is the result of a joint study by Milano-Bicocca, Human Technopole and the London Cancer Research Institute, just published in Nature Communications, which opens up new perspectives for prevention and treatment.
Immagine Ateneo

The pks+ chromosome sequence found in the bacterium Escherichia coli (E.coli) appears to contribute to the development of colorectal cancer. In particular, there would be a link between mutations associated with its presence and alterations in certain genes that are characteristic of this type of cancer. This discovery could open up innovative possibilities for preventive strategies and personalised therapies, particularly in view of the increasing incidence of colorectal cancer, especially in young adults.

This is the conclusion of a study entitled "Contribution of pks+ E.coli mutations to colorectal carcinogenesis", which has just been published in Nature Communications and was carried out thanks to the collaboration between The Institute of Cancer Research (London), Human Technopole and the University of Milan-Bicocca. The research team was led by Bingjie Chen (London), Daniele Ramazzotti (Milano-Bicocca), Trevor A. Graham (London) and Andrea Sottoriva (Human Technopole).

a cura di Redazione Centrale, ultimo aggiornamento il 19/12/2023